Micheal Irelan, | |
Vilseck Army Health Clinic, Vilseck Germany, NY 09112 | |
(314) 590-3847 | |
Not Available |
Full Name | Micheal Irelan |
---|---|
Gender | Male |
Speciality | Family Medicine |
Location | Vilseck Army Health Clinic, Vilseck Germany, New York |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1619433885 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | 32737 (Nebraska) | Primary |
Mailing Address | Practice Location Address |
---|---|
Micheal Irelan, 9040 Jackson Ave, Joint Base Lewis Mcchord, WA 98431-1000 Ph: (253) 968-5509 | Micheal Irelan, Vilseck Army Health Clinic, Vilseck Germany, NY 09112 Ph: (314) 590-3847 |
News Archive
Oceana Therapeutics, a global company focused on acquiring, developing and commercializing best-in-class specialty therapeutics, announced that the U.S. Food and Drug Administration has approved Solesta as a treatment for fecal incontinence in adult patients who have failed conservative therapy such as dietary control.
The University of California, at San Diego and Yale University have been awarded a collaborative grant by the National Science Foundation (NSF) to develop a Neuroscience Gateway (NSG) that gives neuroscientists broadened access to essential high-performance computing (HPC) and storage resources.
All cells have the ability to recycle unwanted or damaged proteins and reuse the building blocks as food. But cancer cells have ramped up the system, called autophagy, and rely on it to escape damage in the face of chemotherapy and other treatments. Now, researchers at the Perelman School of Medicine; the Abramson Cancer Center; and the School of Arts and Sciences, at the University of Pennsylvania, have developed a potent new drug that clogs up the recycling machinery and kills tumor cells in mouse models.
In a recent review article published in the journal ACS Nano, interdisciplinary researchers from across the world evaluated the role of carbon-based nanomaterials (CBNs), such as fullerene, carbon dots, graphene, and their derivatives as promising alternatives to combat COVID-19 (coronavirus disease 2019) and other microbial infections.
› Verified 6 days ago